Skip to content
OpenCapital
Get started

Teladoc Health TDOC Convertible Debt (Non-Current)

Convertible Debt (Non-Current) at other companies

Hims & Hers Health logo
Hims & Hers HealthHIMS
$974.11M—

Other financials

Income statement

See full
Revenue$613.8M-2.5%
Gross profit$416.3M-3.8%
Operating income-$61.8M+48.8%
Net income-$63.8M+31.4%
EPS (diluted)-$0.36+32.1%

Balance sheet

See full
Cash & equivalents$750.7M-37.1%
Total debt$42.2M-92.9%
Total equity$1.3B-6.4%
Total assets$2.8B-18.5%

Cash flow

See full
Operating cash flow$9.5M-40.2%
CapEx$1.7M-39.1%
Free cash flow$7.9M-40.5%

Valuation

See full
Market cap$1.41B+16.5%
Enterprise value$701.31M+14.7%
P/S0.6×+0.1×

Profitability

See full
Gross margin69.3%-1.2pp
Operating margin-8.1%-3.6pp
Net margin-6.8%-3.1pp
FCF margin11.1%-0.2pp

Returns & leverage

See full
Return on equity-12.4%-5.4pp
Debt / equity0×-0.4×
Current ratio2.8×+1.1×

Where this comes from

Reported directly by Teladoc Health in its filing.

Tagged under the XBRL concept us-gaap:ConvertibleDebtNoncurrent.

The official record: Teladoc Health’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Teladoc Health's convertible debt (non-current).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Teladoc Health's convertible debt (non-current)?
Teladoc Health (TDOC) reported convertible debt (non-current) of $995.81M in Q1 2026.
How has Teladoc Health's convertible debt (non-current) changed year-over-year?
Teladoc Health's convertible debt (non-current) increased by 0.4% year-over-year, from $992.29M to $995.81M.
What is the long-term trend for Teladoc Health's convertible debt (non-current)?
Over 5 years (2020 to 2025), Teladoc Health's convertible debt (non-current) has grown at a -6.3% compound annual growth rate (CAGR), from $1.38B to $994.93M.
What does convertible debt (non-current) mean?
This represents the portion of long-term debt obligations that can be converted into equity shares of the company, with maturity dates extending beyond one year. It reflects the company's reliance on hybrid financing structures that balance debt service requirements with potential equity dilution. Investors analyze this metric to evaluate the company's long-term capital structure, interest expense burden, and the potential impact of future share conversion on shareholder value.